BriefTea
Every story in sixty words
Health · 9 hours ago
Enhertu is now available on the NHS for women in England diagnosed with a particular form of incurable breast cancer. On average, the medication extends patients' lives by nearly seven months, and some individuals may experience an additional three years of life. The Enhertu decision affects about 1,000 women a year and comes after campaigners pressed for access since 2024.
Reported by BBC · How we write briefs
Understand this story
What is NHS England?More briefs
WorldFiji's health minister declares HIV a national emergency HealthNew gene-editing tech could help treat drug-resistant fungal infections HealthEating wholegrains every day can lower cholesterol and blood pressure HealthDoctors warn heat from devices causes 'toasted skin syndrome' in children HealthDiabetes drug metformin may slow aging processes, new review suggests HealthSocial media normalises sunbeds, boosts cancer risk. Ban urged. More health stories → Browse all stories →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.